Boston Scientific is dedicated to transforming lives through innovative medical solutions that improve the health of patients around the world. It is a world leader in the development, manufacturing and marketing of minimally invasive medical devices used to diagnose and treat conditions in a variety of medical fields, with an emphasis on Cardiovascular, Cardiac Rhythm Management (CRM), Women’s Health, Urology, Endoscopy, Electrophysiology, Neuromodulation, and Pain Management products. The company has more than 15,000 patents issued, a +13,000 product portfolio, and reached US$7.14 billion in revenue in 2013.
With presence in over 100 countries in the Americas, Europe, the Middle East, Africa, and Asia, and 12 manufacturing facilities globally, Boston Scientific continues to extending its innovations into new geographies and high-growth adjacency markets.
The decision to start operations in Costa Rica was a result of a detailed analysis comparing and assessing several countries. The factors considered were: geographic location, cost, political stability, quality, and talent. Costa Rica´s skilled, well-educated population played an important role in the decision which was made in 2003.
The company started operations about a year later with 139 people at Global Park in Heredia and has had an on-going growth ever since. It did its first Heredia expansion in 2005 and by 2009, it opened a second manufacturing plant (342,000 sq.ft) in Coyol, Alajuela.
This facility was recognized as the country’s first sustainable building (LEED -CI Silver certified) but most importantly hosted the transfer of a Class III cardiovascular device. The company reached over 2.200 employees between the two facilities.
Today, Boston Scientific continues to operate the two plants: Boston Scientific Heredia dedicated to Cardiovascular devices, and Boston Scientific Coyol focused on Endoscopy and Urology applications. 100% of the company´s polypectomy snares and gastrointestinal biopsy forceps are made in Costa Rica.
“Costa Rica has proven to be a compelling, performance-driven location for Boston Scientific. Key drivers for our success at two major sites in Costa Rica include highly committed, multi-disciplined local talent; cross-divisional engagement; growth into R&D, process development and lab competencies; and our close working relationship with CINDE, academia, and the government of Costa Rica.” said Randy Schiestl, VP Global Technology.
A proven success, with over $130 million invested in Costa Rica, has provided Boston Scientific with the needed trust to expand operations and continue to diversify manufacturing products and operations for various divisions.